Filament-producing mutants of influenza A/Puerto Rico/8/1934 (H1N1) virus have higher neuraminidase activities than the spherical wild-type.
Influenza virus exhibits two morphologies - spherical and filamentous. Strains that have been grown extensively in laboratory substrates are comprised predominantly of spherical virions while clinical or low passage isolates produce a mixture of spheres and filamentous virions of varying lengths. The filamentous morphology can be lost upon continued passage in embryonated chicken eggs, a common laboratory substrate for influenza viruses. The fact that the filamentous morphology is maintained in nature but lost in favor of a spherical morphology in ovo suggests that filaments confer a selective advantage within the infected host that is not necessary for growth in laboratory substrates. Indeed, we have recently shown that filament-producing variant viruses are selected upon passage of the spherical laboratory strain A/Puerto Rico/8/1934 (H1N1) [PR8] in guinea pigs. Toward determining the nature of the selective advantage conferred by filaments, we sought to identify functional differences between spherical and filamentous particles. We compared the wild-type PR8 virus to two previously characterized recombinant PR8 viruses in which single point mutations within M1 confer a filamentous morphology. Our results indicate that these filamentous PR8 mutants have higher neuraminidase activities than the spherical PR8 virus. Conversely, no differences were observed in HAU:PFU or HAU:RNA ratios, binding avidity, sensitivity to immune serum in hemagglutination inhibition assays, or virion stability at elevated temperatures. Based on these results, we propose that the pleomorphic nature of influenza virus particles is important for the optimization of neuraminidase functions in vivo.
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Jill
J
Seladi-Schulman
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Patricia J
PJ
Campbell
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Suganthi
S
Suppiah
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
John
J
Steel
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Anice C
AC
Lowen
D000818:Animals; D002642:Chick Embryo; D002645:Chickens; D053118:Influenza A Virus, H1N1 Subtype / Q000201:enzymology / Q000235:genetics / Q000502:physiology*; D005585:Influenza in Birds / Q000821:virology*; D009439:Neuraminidase / Q000378:metabolism*; D017354:Point Mutation; D014763:Viral Matrix Proteins / Q000235:genetics*; D014764:Viral Proteins / Q000378:metabolism*; D014771:Virion / Q000378:metabolism
C488936:M1 protein, Influenza A virus; D014763:Viral Matrix Proteins; D014764:Viral Proteins; D009439:Neuraminidase